*Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL;
†Department of Ophthalmology, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran;
‡Department of Ophthalmology, Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran; and
§Department of Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, FL.
Correspondence: Ali R. Djalilian, MD, Cornea Service, Stem Cell Therapy and Corneal Tissue Engineering Laboratory, Illinois Eye and Ear Infirmary, 1855 W. Taylor St, M/C 648, Chicago, IL 60612 (e-mail: [email protected]).
Supported by R01 EY024349 (A.R.D.), UH3 EY031809 (A.R.D.): Core Grant for Vision Research EY01792 all from NEI/NIH; Vision Research Program—Congressionally Directed Medical Research Program VR170180 from the Department of Defense, Unrestricted Grant to the department and Physician-Scientist Award both from Research to Prevent Blindness.
The authors have no funding or conflicts of interest to disclose.
M. Soleimani and B. Momenaei contributed equally to this study.
